-+ 0.00%
-+ 0.00%
-+ 0.00%

YD Bio 1H FY26 net income swings to USD 6.7 million; revenue rises 315% to USD 846,501

PUBT·08/31/2026 22:00:39
Listen to the news
YD Bio 1H FY26 net income swings to USD 6.7 million; revenue rises 315% to USD 846,501
  • YD Bio posted net income of US$6.7 million as revenue climbed 315% to US$846,501 in the six months ended June 30, 2026.
  • Operating loss widened 66% to US$3.23 million as total operating expenses rose 73% to US$3.5 million.
  • Other income surged to US$9.93 million, driven by a US$9.85 million change in fair value of warrant liabilities.
  • Cash fell to US$2.66 million at June 30, 2026 from US$6.01 million at Dec. 31, 2025.
  • Management highlighted scaling a 47-state lab footprint, a Canadian OkaiDx pilot, and scaled-up exosome manufacturing batches.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. YD Bio Limited published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608311800PRIMZONEFULLFEED9819000) on August 31, 2026, and is solely responsible for the information contained therein.